Acetaminophen Randomized Controlled Trial

• Status: Withdrawn
• Trial end date: 2018-03-19
• Target enrollment: 0
• Participant gender: All

Summary

Patients that are to undergo isolated meniscectomy will be randomized to 2 cohorts: one will take the FDA recommended dose of acetominophen (1000mg) 24hrs before surgery, one will be given a similarly looking placebo pill. A multitude of post-op variables will be included, mainly pain scores and morphine equivalent doses at different time points.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: New York University School of Medicine; NYU Langone Health
• Treatments: Acetaminophen

Criteria

Inclusion Criteria:

• Must be at least 18 years of age

• ASA Class I-II

• Patients scheduled for meniscectomy

Exclusion Criteria:

• Contraindication to acetaminophen (hypersensitivity, extensive alcohol history, liver disease, actively breastfeeding)

• Legally incompetent or mentally impaired (e.g., minors, Alzheimer's subjects, dementia, etc.)

• Younger than 18 years of age or older than 65

• Any patient considered a vulnerable subject

• Patients on pain medication prior to surgery